Lundbeck names former Novo Nordisk CEO Lars Fruergaard Jorgensen as next board chair
Lundbeck names former Novo Nordisk CEO Lars Fruergaard Jorgensen as next board chair Oct 18 (Reuters) - Danish drugmaker H. Lundbeck HLUNa.CO said on Sunday that board chair Dorothea Wenzel will step down at its annual general meeting in 2027, with the board intending to elect former Novo Nordisk NOVOb.CO CEO Lars Fruergaard Jorgensen as her successor.
Jorgensen will join the board as an observer from November 10.
(Reporting by Abu Sultan in Bengaluru; Editing by Jan Harvey)
Recent news on Novo Nordisk A/S
See all newsTrial failures of Novartis, Novo Nordisk heart drugs leave experts guessing
Brief: Novo Real-World Studies Link Wegovy 2.4 MG To Reductions In Liver Enzymes, Weight, Blood Sugar In Adults With Mash
Lilly to sell obesity drugs directly on Hims & Hers site (updated)
Lilly to sell obesity drugs directly on Hims & Hers site
Brief: Executive Martin Holst Lange Sold Novo Shares Worth DKK 3.4 Mln